Tert-butyl N-[2-[2-[[5-(1H-benzimidazol-2-ylcarbamoyl)-1H-imidazole-4-carbonyl]amino]phenyl]ethyl]carbamate
C25H27N7O4 — CID 24984914
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[2-[2-[[5-(1H-benzimidazol-2-ylcarbamoyl)-1H-imidazole-4-carbonyl]amino]phenyl]ethyl]carbamate
Tert-butyl N-[2-[2-[[5-(1H-benzimidazol-2-ylcarbamoyl)-1H-imidazole-4-carbonyl]amino]phenyl]ethyl]carbamate (PubChem CID 24984914) has the molecular formula C25H27N7O4 and a molecular weight of 489.54 g/mol. Its IUPAC name is tert-butyl N-[2-[2-[[5-(1H-benzimidazol-2-ylcarbamoyl)-1H-imidazole-4-carbonyl]amino]phenyl]ethyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[2-[2-[[5-(1H-benzimidazol-2-ylcarbamoyl)-1H-imidazole-4-carbonyl]amino]phenyl]ethyl]carbamate |
|---|---|
| PubChem CID | 24984914 |
| Molecular Formula | C25H27N7O4 |
| Molecular Weight | 489.54 g/mol |
| Exact Mass | 489.21 |
| IUPAC Name | tert-butyl N-[2-[2-[[5-(1H-benzimidazol-2-ylcarbamoyl)-1H-imidazole-4-carbonyl]amino]phenyl]ethyl]carbamate |
| SMILES | CC(C)(C)OC(=O)NCCc1ccccc1NC(=O)c1nc[nH]c1C(=O)Nc1nc2ccccc2[nH]1 |
| InChI | InChI=1S/C25H27N7O4/c1-25(2,3)36-24(35)26-13-12-15-8-4-5-9-16(15)29-21(33)19-20(28-14-27-19)22(34)32-23-30-17-10-6-7-11-18(17)31-23/h4-11,14H,12-13H2,1-3H3,(H,26,35)(H,27,28)(H,29,33)(H2,30,31,32,34) |
| InChIKey | PXNGDZZMUDYNJH-UHFFFAOYSA-N |
| XLogP | 3.86 |
| TPSA | 153.89 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.54 |
| LogP ≤ 5 | 3.86 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 24984914 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.